Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells

An efficient vaccine against human immunodeficiency virus (HIV) must induce good cellular immune responses. To do this, it must be processed and presented by dendritic cells, which are required for primary T-lymphocyte stimulation. We have previously shown that a model lipopeptide containing a short...

全面介紹

書目詳細資料

發表在:	J Virol
Principais autores:	Andrieu, Muriel, Desoutter, Jean-François, Loing, Estelle, Gaston, Jésintha, Hanau, Daniel, Guillet, Jean-Gérard, Hosmalin, Anne
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2003
主題:	Virus-Cell Interactions
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140847/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502869/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.1564-1570.2003
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!